GoodRx Holdings, Inc.

GDRX

US38246G1085

Internet Services

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
7.19 ^USD	+1.55%		+7.47%	+7.31%

Apr. 11	North American Morning Briefing : Stock Futures -2-	DJ
Apr. 10	KeyBanc Upgrades GoodRx to Overweight From Sector Weight on Increased Conviction Around Monthly Active Customers, Sets $9 Price Target	MT

GoodRx Holdings, Inc. authorizes a Buyback Plan.

February 26, 2024

The Board of Directors of GoodRx Holdings, Inc. has authorized a buyback plan on February 27, 2024.

Latest news about GoodRx Holdings, Inc.

North American Morning Briefing : Stock Futures -2-	Apr. 11	DJ
KeyBanc Upgrades GoodRx to Overweight From Sector Weight on Increased Conviction Around Monthly Active Customers, Sets $9 Price Target	Apr. 10	MT
North American Morning Briefing : Traders Await -2-	Apr. 10	DJ
North American Morning Briefing : Markets Steady -2-	Mar. 26	DJ
GoodRx Shares Jump Following Wells Fargo Upgrade, Price Target Boost	Mar. 25	MT
Top Premarket Gainers	Mar. 25	MT
Wells Fargo Upgrades GoodRx Holdings to Overweight From Equalweight, Adjusts Price Target to $10 From $7.50	Mar. 25	MT
Transcript : GoodRx Holdings, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-14-2024 09:00 AM	Mar. 14
Deutsche Bank Adjusts GoodRx Price Target to $9 From $7, Maintains Hold Rating	Mar. 04	MT
North American Morning Briefing : Stock Futures -2-	Mar. 04	DJ
Goldman Sachs Raises GoodRx Holdings' Price Target to $7.50 From $6.50, Maintains Neutral Rating	Mar. 01	MT
UBS Adjusts GoodRx Holdings Price Target to $8 From $5, Maintains Neutral Rating	Mar. 01	MT
TD Cowen Adjusts Price Target on GoodRx Holdings to $14 From $12, Maintains Outperform Rating	Mar. 01	MT
Truist Adjusts Price Target on GoodRx Holdings to $8 From $7.50, Maintains Hold Rating	Mar. 01	MT
JPMorgan Adjusts GoodRx Holdings' Price Target to $7 From $6, Maintains Neutral Rating	Mar. 01	MT
RBC Raises Price Target on GoodRx Holdings to $8 From $7, Keeps Sector Perform Rating	Mar. 01	MT
GoodRx Holdings, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
GoodRx Q4 Adjusted Earnings, Revenue Gain; Sets Q1, 2024 Revenue Outlook; Approves $450 Million Share Buyback Plan	Feb. 29	MT
Transcript : GoodRx Holdings, Inc., Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
Earnings Flash (GDRX) GOODRX HOLDINGS Reports Q4 Revenue $196.6M, vs. Street Est of $195.9M	Feb. 29	MT
Earnings Flash (GDRX) GOODRX HOLDINGS Reports Q4 EPS $0.08, vs. Street Est of $0.07	Feb. 29	MT
North American Morning Briefing : Fed's Preferred -2-	Feb. 29	DJ
GoodRx Holdings, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Goodrx Holdings, Inc. Provides Revenue Guidance for First Quarter 2024 and Fiscal Year 2024	Feb. 29	CI
GoodRx Holdings, Inc. announces an Equity Buyback for $450 million worth of its shares.	Feb. 29	CI

GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.

Sector

Internet Services

Calendar

2024-05-08 - Q1 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for GoodRx Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

7.19 USD

Average target price

8.679 USD

Spread / Average Target

+20.71%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Internet Services

	1st Jan change	Capi.
GOODRX HOLDINGS, INC.	+7.31%	2.7B
TENCENT HOLDINGS LIMITED	+18.66%	414B
NETFLIX, INC.	+15.27%	242B
UBER TECHNOLOGIES, INC.	+12.15%	144B
AIRBNB, INC.	+20.63%	104B
PROSUS N.V.	+17.19%	83.87B
SPOTIFY TECHNOLOGY S.A.	+54.11%	57.64B
DOORDASH, INC.	+33.59%	53.37B
COSTAR GROUP, INC.	+6.02%	37.83B
NASPERS LIMITED	+15.88%	32.51B

Other Internet Services